Home | Products | News | Contact Us
   

Nutraceutical News

Australia rethinks nutrient labelling and health claims standards
EFSA approves new vitamins and minerals for foods and supplements
Children positive on organic, free-range and hormone-free
Calcium sales growth suffering from lack of novelty
West follow East's functional lead?
Women Looking For An Alternative To Black Cohosh






 

Noni Extract


Antiamoebic activity of iridoids from Morinda morindoides leaves.

Cimanga K, Kambu K, Tona L, Hermans N, Apers S, Totte J, Pieters L, Vlietinck AJ.

Department of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium.

An aqueous decoction (dried extract), an 80 % methanolic extract from Morinda morindoides (Rubiaceae) leaves, and five iridoids isolated from the 80 % methanolic extract were evaluated in vitro for their activity against Entamoeba histolytica and their cytotoxicity. The aqueous decoction and the 80 % methanolic extract exhibited a promising antiamoebic activity with IC (50) values of 3.1 +/- 1.7 and 1.7 +/- 0.6 microg/mL, respectively. All tested iridoids displayed antiamoebic activity, the most active being epoxygaertneroside (IC (50): 1.3 +/- 0.4 microg/mL) and methoxygaertneroside (IC (50): 2.3 +/- 0.7 microg/mL) followed by gaertneroside, acetylgaertneroside and gaertneric acid with IC (50) values of 4.3 +/- 1.8, 5.4 +/- 1.4 and 7.1 +/- 1.4 microg/mL, respectively. Synergistic effects between the iridoids tested, or with other constituents, may explain the high activity of the extracts. All extracts and iridoids were devoid of any cytotoxic effect against MT-4 cells at the highest test concentration of 250 microg/mL. These findings support at least in part the traditional use of Morinda morindoides leaves for the treatment of amoebiasis in the Democratic Republic of Congo.

PMID: 16732537 [PubMed - indexed for MEDLINE]


<< Back to All Natural Products List

© Copyright 2007 - Nutraceutical Ingredients - All Rights Reservec